Page last updated: 2024-12-08

glucosamine 1-phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID188960
CHEBI ID27625
SCHEMBL ID285055
MeSH IDM0115878

Synonyms (26)

Synonym
2-amino-2-deoxy-alpha-d-glucopyranose 1-(dihydrogen phosphate)
CHEBI:27625
GP1 ,
2-amino-2-deoxy-1-o-phosphono-alpha-d-glucopyranose
2152-75-2
alpha-d-glucosamine 1-phosphate
d-glucosamine 1-phosphate
C06156
glucosamine 1-phosphate
DB03111
[(2r,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl] dihydrogen phosphate
alpha-d-glucopyranose, 2-amino-2-deoxy-, 1-(dihydrogen phosphate)
SCHEMBL285055
.alpha.-d-glucopyranose, 2-amino-2-deoxy-, 1-(dihydrogen phosphate)
YMJBYRVFGYXULK-QZABAPFNSA-N
DTXSID70175855
J-014131
(2r,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl dihydrogen phosphate
(2r,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yldihydrogenphosphate
alpha -d-glucosamine 1-phosphate
a-d-glucosamine 1-phosphate free acid
{[(2r,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phosphonic acid
CS-0835704
HY-154871
BSG3MU7VAE
2-amino-2-deoxy-alpha-d-glucopyranosyl phosphate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
glucosamine phosphateA hexosamine phosphate having glucosamine as the amino sugar component.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
peptidoglycan and lipid A precursor biosynthesis034

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (15.79)18.7374
1990's3 (15.79)18.2507
2000's3 (15.79)29.6817
2010's9 (47.37)24.3611
2020's1 (5.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.61 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index32.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]